Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-14 Purchase | 2023-12-18 5:10 pm | Carmell Corp | CTCX | Gregory Kathryn Director | 1,130 | $3.8233 | $4,320 | 81,112 (Indirect Direct) | View |
| 2023-12-11 Purchase | 2023-12-13 9:36 pm | Carmell Corp | CTCX | Gregory Kathryn Director | 3,261 | $4.2 | $13,696 | 54,140 (Indirect Direct) | View |
| 2023-12-04 Purchase | 2023-12-08 9:14 pm | Carmell Corp | CTCX | Gregory Kathryn Director | 2,336 | $3.0333 | $7,086 | 50,751 (Indirect Direct) | View |
| 2019-08-13 Purchase | 2019-08-15 4:16 pm | AILERON THERAPEUTICS INC | ALRN | Gregory Kathryn SVP, Chief Business Officer | 45,000 | $0.645 | $29,025 | 45,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-23 Other | 2023-12-18 5:10 pm | N/A N/A | Carmell Corp | CTCX | Gregory Kathryn Director | 0 | $0 | 81,112 (Direct) | View |
| 2021-09-23 Other | 2023-12-13 9:36 pm | N/A N/A | Carmell Corp | CTCX | Gregory Kathryn Director | 0 | $0 | 54,140 (Direct) | View |
| 2023-12-08 Other | 2023-12-08 9:14 pm | N/A N/A | Carmell Corp | CTCX | Gregory Kathryn Director | 0 | $0 | 50,751 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 8:41 pm | N/A 2030-07-17 | ALPHA HEALTHCARE ACQUISITION CORP III | CTCX | Gregory Kathryn Director | 76,878 | $0 | 76,878 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:30 pm | N/A 2030-01-30 | AILERON THERAPEUTICS INC | ALRN | Gregory Kathryn SVP, Chief Business Officer | 185,000 | $0 | 185,000 (Direct) | View |